[Effect of percutaneous coronary intervention on QT dispersion and its clinical implication in patients with acute

Chun-hua Bei1, Yi Luo, Guang-lian Li

  • 1Department of Cardiology, First People's Hospital of Guangzhou, Guangzhou 510180, China.

Di 1 Jun Yi Da Xue Xue Bao = Academic Journal of the First Medical College of PLA
|September 28, 2004
PubMed

Insights

Percutaneous coronary intervention (PCI) significantly reduces QT dispersion (QTd) in acute myocardial infarction (AMI) patients. Earlier PCI intervention leads to better QTd reduction, highlighting the importance of timely treatment for AMI.

Area of Science:

  • Cardiology
  • Electrophysiology

Context:

  • Acute myocardial infarction (AMI) poses significant risks.
  • QT dispersion (QTd) is a marker of cardiac electrical instability.
  • Percutaneous coronary intervention (PCI) is a primary treatment for AMI.

Purpose:

  • To evaluate the impact of PCI on QT dispersion (QTd) in AMI patients.
  • To assess the clinical significance of PCI-induced changes in QTd.
  • To explore the relationship between the timing of PCI and QTd outcomes.

Summary:

  • PCI demonstrated a significant reduction in QT dispersion (QTd) and heart rate-corrected QT dispersion (QTcd) in AMI patients.
  • No significant changes were observed in QT interval (QT) or corrected QT interval (QTc) post-PCI.
  • Earlier PCI intervention (within 6 hours) resulted in greater QTd and QTcd reduction compared to later intervention.

Impact:

  • Successful PCI can improve cardiac electrical stability by reducing QTd.
  • Timely PCI intervention in AMI is associated with more favorable electrophysiological outcomes.
  • These findings underscore the importance of prompt reperfusion therapy in managing AMI and its electrical complications.
Abstract

Related Concept Videos

Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...